Overview
Acme United Q3 sales rose 2% yr/yr but missed analyst expectations
Net income for Q3 fell 14% due to higher tax rate
Company's first aid revenues increased 9% amid strong online and refill sales
Outlook
Acme United is experiencing increased promotional activity
Company continues to manage through tariff-related uncertainties
Result Drivers
FIRST AID SALES - Strong online and refill sales boosted first aid revenues by 9%
TARIFF IMPACT - Tariff environment led to reduced sales of Westcott cutting tools and cancellation of retail promotions
OPERATING INCOME - Operating income increased 3% despite challenges, supported by effective management
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | Miss | $49.06 mln | $50.70 mln (2 Analysts) |
Q3 Net Income | $1.9 mln | ||
Q3 Basic EPS | $0.50 | ||
Q3 Gross Profit | $19.19 mln | ||
Q3 Operating Income | $3 mln | ||
Q3 Pretax Profit | $2.43 mln |
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Acme United Corp is $50.50, about 23.9% above its October 20 closing price of $38.45
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 18 three months ago
Press Release: ID:nGNXb4NXGl
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)